Skip to main content

Table 1 (abstract A5). Immunomodulatory Medication Use in Youth with Newly-Diagnosed SLE, N=650

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Proportion with prescription fills after first SLE diagnosis code, n (%)

Within 3 months

Within 6 months

Within 1 year

Immunomodulatory medication (hydroxychloroquine or immunosuppressant)

428 (66)

460 (71)

511 (78)

Hydroxychloroquine

374 (58)

407 (63)

457 (70)

Immunosuppressant

114 (18)

162 (25)

221 (34)

  1. Immunosuppressant medications include: mycophenolate mofetil, azathioprine, leflunomide, methotrexate, tacrolimus, and oral cyclophosphamide